Sector: MedicalCrucell NV (NASDAQ: CRXL)
Headlines
- Crucell launches global brand to reflect and reinforce its leading position in healthcare innovation
Nov 16, 2009 01:54 AM | CRXL
- Crucell launches global brand to reflect and reinforce its leading
position in healthcare innovation
Nov 16, 2009 01:46 AM | CRXL
- TapImmune Signs License Agreement With Crucell N.V.
Nov 05, 2009 09:02 AM | CRXL
- Stocks on the Move: TPIV, INO, MBCI, CRXL
Nov 05, 2009 08:19 AM | CRXL, INO
- TapImmune Signs License Agreement With Crucell N.V.
Nov 04, 2009 09:01 AM | CRXL
- Calmune and Crucell Enter Exclusive Research Collaboration
Nov 03, 2009 03:00 AM | CRXL
- Crucell Announces Third Quarter 2009 Results
Nov 03, 2009 01:46 AM | CRXL
- Sorrento Therapeutics Announces the Appointment of Martina Molsbergen as Vice President, Business Development
Oct 27, 2009 08:02 AM | CRXL
- Crucell to Release Q3 2009 Results on Tuesday November 3, 2009
Oct 27, 2009 07:03 AM | CRXL
- Crucell HIV Vaccine: Promising Preliminary Results Phase I Study Presented by Dr Dan Barouch at AIDS Vaccine 2009 in Paris
Oct 21, 2009 06:36 AM | CRXL
- J&J posts 1 percent profit rise despite sales drop
Oct 13, 2009 11:51 AM | CRXL, ELN, JNJ
- J&J posts 1 percent profit rise despite sales drop
Oct 13, 2009 09:51 AM | CRXL, ELN, JNJ
- Pa. Isn't Expected to Lose Jobs When Pfizer Acquires Wyeth
Sep 30, 2009 01:17 PM | ABT, CRXL, CSL, JNJ, PFE, SGP
- Pa. Isn't Expected to Lose Jobs When Pfizer Acquires Wyeth
Sep 30, 2009 06:13 AM | ABT, CRXL, CSL, JNJ, PFE, SGP
- Johnson & Johnson, Xerox, Abbott Labs big movers
Sep 28, 2009 05:53 PM | ABT, ACN, ACS, AMAT, CALM, CRXL
- Earnings roundup: Broadridge Financial, Fossil
Aug 11, 2009 11:00 AM | BR, CRXL, QGEN
- Crucell Receives NIH Award for the Development of Influenza Monoclonal Antibodies
Aug 18, 2009 01:52 AM | CRXL
- New awards of $300 million for Quinvaxem(R) bringing total value up to $800 million
Aug 17, 2009 01:53 AM | CRXL
- Crucell Announces Second Quarter 2009 Results
Aug 11, 2009 04:00 AM | CRXL
- StockPreacher.com Issues Trading Outlook for Novavax Inc.
Aug 03, 2009 06:51 AM | CRXL, MRK, NVAX, QDEL, VICL
- MVI and Crucell Announce Collaboration new Malaria Vaccine Approach
Jul 29, 2009 02:04 AM | CRXL
- Crucell Announces Positive Results of Phase II Rabies Monoclonal Antibody Combination Clinical Study in Philippines
Jun 24, 2009 01:55 AM | CRXL
- Xcellerex Announces Sale of FlexFactory™ Bioproduction Line to Crucell for Vaccine, Monoclonal Antibody Manufacturing Facility
Jun 17, 2009 08:40 AM | CRXL
- Crucell 2009 Annual General Meeting of Shareholders 2008 Financial Statements Adopted; All Resolutions Approved
Jun 05, 2009 11:55 AM | CRXL
- Crucell to Release First Quarter 2009 Results on Wednesday, May 6, 2009
Apr 29, 2009 10:42 AM | CRXL
- Reportlinker Adds World Pharmaceutical Contract Manufacturing Market Report
Mar 19, 2009 09:54 AM | CAH, CRXL, PFE, SFE
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
CRXL
|
Compare to S&P
|
| YTD |
38.28 %
|
14.23 %
|
| 4 Weeks |
-1.32 %
|
-1.84 %
|
| 12 Weeks |
-7.79 %
|
-13.47 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 650.00 %
|
|
EPS Growth in Last Year: -24.14 %
|
|
Sales Growth in Last Quarter: 41.13 %
|
|
Sales Growth in Last Quarter: 12.51 %
|
|
